Created: September 11, 2017
Last update: September 18, 2017
House of Commons Health Committee
considers BILL C-45 (cannabis, marijuana)
September 11, 2017 to September 15, 2017 recorded testimony on the government’s BILL C-45 (cannabis, marijuana).
Watch the hearings live on CPAC.ca
In Committee from the House of Commons Marijuana
Health committee – September 11, 2017 – Part 1
The committee reconvenes a week ahead of Parliament’s return to begin its hearings on C-45, the government’s bill to legalize marijuana. The proposed Cannabis Act would create a legal framework to control the production, distribution, sale and possession of recreational marijuana in Canada. Sales will be restricted to people age
Health committee – September 11, 2017 – Part 2
Former justice minister Anne McLellan, who chaired the federal task force on marijuana legalization, testifies as the committee continues its hearings on Bill C-45
Health committee – September 11, 2017 – Part 3
MPs continue their hearings on the government’s cannabis legislation (C-45), with a panel on provincial responsibilities and perspectives from the cannabis industry. The committee hears from Philippe Lucas (executive director, Canadian Medical Cannabis Council), Keith Jones (chair, government relations) and Robert Rae (director), both with the Canadian Hemp Trade Alliance
Health committee – September 11, 2017 – Part 4
Canadian Medical Association president Laurent Marcoux and his colleague Jeff Blackmer (vice-president of medical professionalism) are among the witnesses to testify as the committee continues its review of C-45, the federal government’s marijuana legalization bill. MPs also hear from Trevor Bhupsingh (director general, Law Enforcement and Border Strategies Directorate
Health committee – September 12, 2017 – Part 1
The following witnesses testify on Bill C-45: Thomas Carrique (deputy chief) and Mike Serr (deputy chief constable, drug advisory committee), who are all representing the Canadian Association of Chiefs of Police; Rick Barnum (deputy commissioner, investigation and organized crime) from the Ontario Provincial Police; and Mark Chatterbok (deputy chief of operations) with the Saskatoon Police Service
Health committee – September 12, 2017 – Part 2
The committee discusses justice and public safety issues as it continues its hearings on the government’s marijuana legislation (C-45). MPs hear from Neil Boyd (criminology professor, Simon Fraser University); Christian Leuprecht (political science professor, Royal Military College of Canada); Barreau du Québec representatives Paul-Matthieu Grondin (president), Luc Hervé Thibaudeau
Health committee – September 12, 2017 – Part 3
The committee hears about the experiences of other jurisdictions as it continues its review of the government’s marijuana legislation (C-45). The witnesses are Sam Kamin (professor of marijuana law and policy, University of Denver); Michael Hartman (executive director, Colorado Department of Revenue); Marc-Boris St-Maurice (NORML Canada) and Abigail Sampson (NORML Canada)
Health committee – September 12, 2017 – Part 4
MPs continue their review of Bill C-45, the federal government’s proposal to legalize marijuana. Committee members hear from Marco Vasquez (retired Colorado police chief), Andrew Freedman (Colorado’s former director of marijuana coordination) Kevin Sabet (president, Smart Approaches to Marijuana), and Kristi Weeks (government relations director, Washington State Department of Health)
Health committee – September 13, 2017 – Part 1
The committee holds its third day of hearings on C-45, the federal government’s Cannabis Act.
Jonathan Page (chief executive officer, Anandia Labs), John Conroy (criminal defence lawyer) (president NORML Canada) and John Dickie (president, Canadian Federation of Apartment Associations) take part in a panel on the household cultivation of cannabis plants. Under the proposed bill, adults would legally be able to grow up to four plants per household.
Health committee – September 13, 2017 – Part 2
MPs hear from Scott Bernstein (senior policy analyst, Canadian Drug Policy Coalition); Ian Culbert (executive director, Canadian Public Health Association); Dr. Christina Grant (member of the Canadian Paediatric Society’s adolescent health committee); Judith Renaud and Paul Renaud (respectively executive director and communications director, Educators for Sensible Drug Policy); and Peter A. Howlett (president)and Peter Vamos (executive director), both representing the organization Portage, which operates drug rehabilitation programs.
Health committee – September 13, 2017 – Part 3
MPs hear from the following witnesses on Bill C-45: Amy Porath (director of research and policy, Canadian Centre on Substance Use and Addiction); Drug Free Kids Canada representatives Marc Paris (executive director) and William J. Barakett (member of advisory council); and Maude Chapados and François Gagnon (scientific advisors, Institut national de santé publique du Québec).
Health committee – September 13, 2017 – Part 4
The following witnesses offer their viewpoints: Dr. Gabor Maté (addiction expert); Centre for Addiction and Mental Health representatives Benedikt Fischer (senior scientist, Institute for Mental Health Policy Research) and Bernard Le Foll (medical head, Addiction Medicine Service, Acute Care Program); Dr. Eileen de Villa (Toronto’s medical officer of health); Dr. Sharon Levy (director of the Adolescent Substance Abuse Program at Boston Children’s Hospital); as well as Michelle Suarly and Elena Hasheminejad (members of Ontario Public Health Association’s Cannabis Task Group).
Health committee – September 14, 2017 – Part 1
The following witnesses discuss prevention, treatment, and low-risk use: Michael DeVillaer (assistant professor, department of psychiatry and behavioural neurosciences, McMaster University); Mark Kleiman (professor of public policy, Marron Institute of Urban Management, New York University; Lynda G. Balneaves, (medical and non-medical cannabis researcher) and Karey Shuhendler (policy advisor, policy, advocacy and strategy), both from with the Canadian Nurses Association; Dr. Serge Melanson (New Brunswick Medical Society); and Dr. Robert Strang (Nova Scotia’s chief medical officer of health).
Health committee – September 14, 2017 – Part 2
Trina Fraser (lawyer and cannabis law expert) and Norm Keith (lawyer specializing in occupational health and safety) testify. Brenda Baxter, an official with the Department of Employment and Social Development’s workplace directorate, is the other witness.
Health committee – September 14, 2017 – Part 4 (3)
Witnesses discuss labelling and packaging as the committee holds another hearing on the government’s cannabis legislation (C-45). The panellists are David Hammond (professor, University of Waterloo’s School of Public Health and Health Systems), Mike Hammoud (president Atlantic Convenience Stores Association), and Non-Smokers’ Rights Association representatives Melodie Tilson (director of policy) and Pippa Beck (senior policy analyst).
Health committee – September 14, 2017 – Part 5 (4)
The witnesses for this panel are Steven Hoffman (professor, York University’s Faculty of Health), Beau Kilmer (co-director, RAND Drug Policy Research Centre), Kirk Tousaw, (criminal defence lawyer) (NORML Canada) and advocate for repealing cannabis prohibition), and Stephen Rolles (senior policy analyst, Transform Drug Policy Foundation).
Health committee – September 15, 2017 – Part 1
Ryan Vandrey (associate professor of psychiatry and behavioral sciences at Johns Hopkins University), Daniel Vigil (manager of marijuana health monitoring and research, Colorado Department of Public Health and Environment) and Dana Larsen (director, Sensible BC) are the witnesses for this panel.
Health committee – September 15, 2017 – Part 2
The witnesses for this session are BC Compassion Club Society representatives Hilary Black (founder) and Marcel Vandebeek (administrator), Jonathan Zaid (executive director) and Daphnée Elisma (Quebec representative), who are both with the group Canadians for Fair Access to Medical Marijuana, and the Department of Health’s Jacqueline Bogden (assistant deputy minister, Cannabis Legalization and Regulation Branch).
Health committee – September 15, 2017 – Part 3
Marijuana activists Marc and Jodie Emery take part in the committee’s hearings on Bill C-45, the federal government’s proposal to legalize recreational marijuana.
Lisa Holmes (mayor of Morinville, Alberta and president of the Alberta Urban Municipalities Association), Brock Carlton (CEO, Federation of Canadian Municipalities) and Bill Karsten (second vice-president, FCM) are the other witnesses for this panel on municipalities.
September 11, 2017
Health committee hears from senior government officials, RCMP on pot legislation
A senior RCMP officer says it would be “naive” to think organized crime in the cannabis market will be eliminated with the legalization of recreational marijuana.
2017 has proven to be a historic year in cannabis history. Through our annual conference, we bring together experts from all walks of the cannabis space, to help educate and engage Canadians in open, productive and thoughtful dialogue.
Saturday, September 9th, 2017
11:00 AM – NORML Canada – Opening Address
11:15 AM – Jamie Shaw (MMJ Canada), Irie Sellkirk (Emblem), Dessy Pavlova (CSSDP/Lift), Amy Brown (Canndo) – Women and Cannabis Panel
12:30 PM – Britney Guerra – Cannabis Entrepreneurship – Challenges and Triumphs
1:30 PM Lunch Break
2:00 PM – Alison Gordon – Navigating Businesses into the Legal Cannabis Market
3:00 PM – Marcus Richardson (Bubbleman), Kevin Furet (Cannabis Wheaton), Jose Domingez (Canveda), Matt Rogge (7Acres) – Cannabis Growing- Personal, Patients and Large Production
4:00 PM – Dana Larsen – Keynote
5:00 PM – Marcus Richardson – Bubbleman Brand
6:00 PM – Jodie Emery – The Princess of Pot
7:00 PM – NORML Canada – Closing Day 1 Remarks – John Conroy
Sunday September 10th
11:00 AM – NORML Canada – Welcome
11:15 AM – MP Nathaniel Erskine Smith – Keynote
12:30 PM – David Schaefer (BHOGart) Safe Extraction Methods
1:30 PM – Lunch
2:00 PM – Alan Park – Canadian Comedian Cures Cancer with Cannabis Oil
3:00 PM – Adam Greenblatt (Canopy Growth), Matt Mernagh (Peace Naturals), John Fowler (Supreme), Kevin Furet (Cannabis Wheaton), Shega Youngson (Canopy Growth) – From Grey to Green – Transitioning Into the Legal Cannabis Market.
4:00 PM – Paul Lewin – Dispensaries- The Legal Challenges and Legalization
5:00 PM – Executive Directors of NIMCA – the National Indigenous Medical Cannabis Association
6:00 PM – Jonathan Zaid (CFAMM) – Cannabis and Driving
6:30 PM – NORML Canada Conference Closing Remarks – John Conroy
We can’t help but feel the cannabis act is more decriminalization then legalization. Also of much concern is the criminal penalties and restrictions are much more harsher for cannabis then alcohol, tobacco and even many violent crimes.
Note: The impaired driving likely won’t hold up to constitutional challenges in the courts. calgary420.ca/pdf/driving/driving-impaired.pdf
Growing restricted to 4 plants per home and 1 meter height max. Tobacco cultivation limit is 15kg per year for each adult person living at the residence.
Note: Easy enough to control height with plant training.
April 13, 2017
Government of Canada news release (legalize cannabis legislation) (PDF)
Government of Canada Cannabis Act (PDF)
April 13, 2017
Emily Mertz, Web Producer – Global News Calgary
What do you think the legal minimum age to buy marijuana in Alberta should be?
See age poll left side after “City of Calgary” and before “Calgary 420 Cannabis Community”
September 4, 2002 marks the release of the Senate Special Committee on Illegal Drugs: “Cannabis: Our Position for a Canadian Public Policy.” with a recommended 16 year old age limit for consuming cannabis.
April 13, 2017
Shaun Frenette – CTV Calgary News
Re: Concerns about youth and driving under proposed marijuana laws.
Cannabis and impaired driving – PDF document calgary420.ca/pdf/driving/driving-impaired.pdf
Re: Calgary Mayor Naheed Nenshi brain science comment:
The long term real world schizophrenia data from the nineteen sixties (1960s) to twenty sixteen (2016) shows no sufficient increases even thought cannabis consumption has sufficiently increased over the same time period (over 50 years).
April 15, 2017
Mike Blanchard – 660 News Radio
A local marijuana advocate is urging the Alberta government to keep pot out of liquor stores once the stuff becomes legal
Q&A Banff cannabis store bust highlights ‘blowback’ against recreational pot sales in Alberta, advocate says
On Tuesday, RCMP in Banff shut down a newly-opened weed shop
CBC News Posted: Jan 13, 2017
The Final Report of the Task Force on Cannabis Legalization and Regulation
Table of Contents
Chapter 2: Minimizing Harms of Use
• Introduction: a public health approach
• Minimum age
• Promotion, advertising and marketing restrictions
• Cannabis-based edibles and other products
• THC potency
• Tax and price
• Public education
• Prevention and treatment
• Workplace safety
• Annex 1: Biographies of Task Force on Cannabis Legalization and Regulation Members
• Annex 2: Terms of Reference
• Annex 3: Acknowledgements
• Annex 4: Discussion Paper ‘Toward the Legalization, Regulation and Restriction of Access to Marijuana’
• Annex 5: Executive Summary: Analysis of consultation input submitted to the Task Force on Cannabis Legalization and Regulation
Access to Cannabis for Medical Purposes Regulations (ACMPR)
August 24, 2016
Part 2 — Production for Own Medical Purposes and Production by a Designated Person
Part 2 of the ACMPR sets out a registration framework that allows for personal-use and designated production of cannabis (including cultivation of plants and alteration of products) for medical purposes.
Note: The majority of Part 2 incorporates the requirements of the former MMAR and relevant section 56 CDSA exemptions that respond to the decision in R. v. Smith with required modifications to incorporate the production, storage and possession of products other than dried marihuana or plants. New provisions that did not form part of the previous framework include the following:
•Proof of possession and registration can be demonstrated through a registration certificate issued by Health Canada.
• Starting materials (i.e. seeds and plants) can be obtained through licensed producers.
• Interim supply of cannabis (until plants are ready) can be obtained through licensed producers.
• Security measures do not need to be listed on the registration application, but those registering to possess and produce cannabis must declare that security measures are in place to keep plants and products secure.
• Information sharing provisions have been expanded to enable proactive sharing of information on registered persons with P/T health care licensing authorities.
Indoor & outdoor grams, plants and storage amounts.
Grams Per Day = Plant Count
Producing cannabis safety and security
Information bulletin: safety and security considerations when producing cannabis for your own medical purposes
Applications for Production for Own Medical Purposes and Production by a Designated Person
Guidance Document – Completing the Production for Own Medical Purposes and Production by a Designated Person Registration Form
Licensed dealer testing of cannabis produced by individuals
August 11, 2016 Understanding ACMPR
Understanding the New Access to Cannabis for Medical Purposes Regulations
Complete ACMPR Regulations
Contact Health Canada Cannabis for medical purposes
Toll Free Phone: 1-866-337-7705
More Cannabis for medical purposes services and information
Health Canada Cannabis for medical purposes
Task force and public consultation to inform creation of a new system that will protect and inform Canadians
June 30, 2016
Ottawa, ON – Government of Canada – News Release
Participate by providing your input by completing the online consultation
Toward the Legalization, Regulation and Restriction of Access to Marijuana – Discussion Paper
or skip directly to participate in “online consultation”, locate the “Next” button at “Accessing Marijuana for Medical Purposes” “Privacy Notice”
or see “How to participate” “Provide feedback on minimizing harms of use by completing the “online consultation.” link above the “Previous” and “Next” buttons on the following five pages: 3.1 Minimizing harms of use, 3.2 Establishing a Safe and Responsible Production System, 3.3 Designing an appropriate distribution system, 3.4 Enforcing public safety and protection and 3.5 Accessing Marijuana for Medical Purposes
Cannabis Legalization and Regulation Secretariat
Address locator 0602E
Ottawa, ON K1A 0K9
Dr. Susan C. Boyd, Killer Weed: Marijuana Grow Ops, Media and Justice.
The Canadian Press — Dec. 25, 2013
Book by B.C. researcher says media, police not talking straight on pot
Susan C. Boyd, BC BookLook – April 17th, 2014 Reefer madness is governmental
Dr. Mark A Ware,
Executive Director of The Canadian Consortium for the Investigation of Cannabinoids (CCIC).
Dr. Perry Kendall, British Columbia Provincial Health Officer
November 10, 2014 Vancouver Sun
Dr. Perry Kendall reflects on 15 years as British Columbia’s Provincial Health Officer